We're an AI-native biotech working on replacing needles with pills.
$200B
of treatable diseases and validated human biology without a pill.
Discovery programs lack a tractable chemical starting point, which makes this a zero-shot inference problem. Because these targets have no training data, LLMs and other historical interpolative AI approaches are insufficient.
Instead, we are building our own extrapolative frontier models that reason beyond their training data.
Most critically, we have repeatedly validated our platform on both our own and partner programs.